New Delhi: Bharat Biotech’s Covaxin is effective against the UK variant of the virus. Taking to Twitter, Bharat Biotech said “Covaxin effectively neutralises UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape”. The tweet also enclosed a link to a report of its research findings. However, the study is yet to be peer-reviewed, ZeeNews reported.
The UK variant of the virus is considered to be 70 percent more infectious and more lethal than Wuhan one. In India, 150 cases of the UK strain have been reported.
Covaxin was approved for emergency use by the drug regulatory authority in January. The regulator, however, said the vaccine’s use will be in the clinical trial mode, which means all its recipients will be tracked and monitored, the report added.
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.